The euphoria, the warnings and the downfall of the current bioresorbale stents: could the journey be restarted?

참고문헌 (15)

1. Osung Kwon, "Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea", The Korean Journal of Internal Medicine, 33(5), pp.922~932 (2018), 대한내과학회[DOI]
2. Tamai H, "Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans", Circulation, 102, pp.399~404 (2000)[DOI]
3. Ormiston JA, "A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial", Lancet, 371, pp.899~907 (2008)[DOI]
4. Onuma Y, "Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial", EuroIntervention, 6, pp.447~453 (2010)[DOI]
5. Onuma Y, "Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial", JACC Cardiovasc Interv, 6, pp.999~1009 (2013)[DOI]
6. Ho HH, "Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases", Heart Vessels, 30, pp.545~548 (2015)[DOI]
7. Kounis NG, "Bioabsorbable stent thrombosis Quo Vadis: is Kounis syndrome still present?", Int J Cardiol, 176, pp.305~306 (2014)[DOI]
8. Lendlein A, "Biodegradable, elastic shape-memory polymers for potential biomedical applications", Science, 296, pp.1673~1676 (2002)[DOI]
9. Bostman O, "Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review", Biomaterials, 21, pp.2615~2621 (2000)[DOI]
10. Ji W, "Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation", Biomaterials, 33, pp.6604~6614 (2012)[DOI]
11. Kounis NG, "Where are the secrets of increased thrombosis and aneurysm formation with the current bioresorbable vascular scaffolds hidden?", Circ J, 82, pp.608~609 (2018)[DOI]
12. Kounis NG, "Bioresorbable stents: quo vantis?", J Thorac Dis, 9, pp.E1032~E1034 (2017)[DOI]
13. Wykrzykowska JJ, "Bioresorbable scaffolds versus metallic stents in routine PCI", N Engl J Med, 376, pp.2319~2328 (2017)[DOI]
14. Ali ZA, "2-Year outcomes with the absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy", Lancet, 390, pp.760~772 (2017)[DOI]
15. Sorrentino S, "Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents", J Am Coll Cardiol, 69, pp.3055~3066 (2017)[DOI]

관련 논문AI추천